Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RapiDO: Doravirine in Rapid Initiation of HAART in HIV-1
NCT07357584Phase 4Recruiting
- Sponsor
- Fundación Huésped
- Start
- Sep 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doravirine, lamivudine, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Fundación Huésped. Started Sep 2026; status: recruiting.
02
Drugs
doravirinelamivudinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07357584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07357584.